California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a pathway for the substitution of interchangeable biologic medicines.
Despite fierce opposition from insurance companies and large pharmacy chains, it is now on its way to the Governor’s desk. It’s critical for him to understand that this issue is one of the highest priorities for patients, healthcare providers and the life sciences industry.
Senate Bill 598 is needed now to update current law and allow pharmacists to automatically substitute a new class of biologic medicines, called biosimilars, for a brand biologic when the biosimilar is deemed interchangeable by the FDA.
Without SB 598, biosimilars cannot be substituted at California pharmacies – even if they are FDA-approved.
The bill also requires that a patient’s physician is notified which biologic medicine is dispensed. SB 598 will help make these new biologic medicines which treat serious illnesses like cancer, multiple sclerosis and Alzheimer’s more accessible for Californians while maintaining the sanctity of the patient-physician relationship.
If you live or work in California, please send in your support letter today and let Governor Brown know how important this bill is to you!
Our friends at the California Healthcare Institute created this easy to use tool that allows you to send your message in just a few seconds.
To have the greatest impact, letters need to be sent to the Governor’s office by September 27, 2013.
Thanks for your support!